Intellectual Property and the Pharmaceutical Industry: A Moral Crossroads Between Health and Property

The moral justification of intellectual property is often called into question when placed in the context of pharmaceutical patents and global health concerns. The theoretical accounts of both John Rawls and Robert Nozick provide an excellent ethical framework from which such questions can be clarif...

Full description

Saved in:  
Bibliographic Details
Authors: Amado, Rivka (Author) ; Gewertz, Nevin M. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Springer Science + Business Media B. V 2004
In: Journal of business ethics
Year: 2004, Volume: 55, Issue: 3, Pages: 295-308
Further subjects:B Patents
B Nozick
B Global trade
B Intellectual Property
B AIDS
B Pharmaceutical
B Rawls
Online Access: Presumably Free Access
Volltext (JSTOR)
Volltext (lizenzpflichtig)

MARC

LEADER 00000caa a22000002 4500
001 1785622919
003 DE-627
005 20230427062126.0
007 cr uuu---uuuuu
008 220112s2004 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10551-004-0993-z  |2 doi 
035 |a (DE-627)1785622919 
035 |a (DE-599)KXP1785622919 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Amado, Rivka  |e VerfasserIn  |4 aut 
245 1 0 |a Intellectual Property and the Pharmaceutical Industry: A Moral Crossroads Between Health and Property 
264 1 |c 2004 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a The moral justification of intellectual property is often called into question when placed in the context of pharmaceutical patents and global health concerns. The theoretical accounts of both John Rawls and Robert Nozick provide an excellent ethical framework from which such questions can be clarified. While Nozick upholds an individual’s right to intellectual property, based upon its conformation with Lockean notions of property and Nozick’s ideas of just acquisition and transfer, Rawls emphasizes the importance of basic liberties, such as an individual’s right to health, superceding such secondary rights as intellectual property rights. From a policy perspective, patent protection for pharmaceutical products necessarily entails the balancing of corporate intellectual property interests and public interests in healthcare. The moral dilemma that occurs when these two interests clash is not easily resolved. Aside from corporate and public interests, the state maintains an interest in creating and preserving policies that regulate the moral dilemma itself. This paper analyzes the economic and ethical factors surrounding the production and distribution of the anti-HIV medication, AZT. Potential policy implications and recommendations are also discussed. 
601 |a Industrie 
650 4 |a Rawls 
650 4 |a Pharmaceutical 
650 4 |a Patent 
650 4 |a Nozick 
650 4 |a Intellectual Property 
650 4 |a Global trade 
650 4 |a Aids 
700 1 |a Gewertz, Nevin M.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of business ethics  |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1982  |g 55(2004), 3, Seite 295-308  |h Online-Ressource  |w (DE-627)270937129  |w (DE-600)1478688-6  |w (DE-576)121465284  |x 1573-0697  |7 nnns 
773 1 8 |g volume:55  |g year:2004  |g number:3  |g pages:295-308 
856 |3 Volltext  |u http://www.jstor.org/stable/25123392  |x JSTOR 
856 |u https://philarchive.org/rec/AMAIPA-2  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h repository [oa repository (via OAI-PMH title and first author match)] 
856 4 0 |u https://doi.org/10.1007/s10551-004-0993-z  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
935 |a mteo 
936 u w |d 55  |j 2004  |e 3  |h 295-308 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4033681787 
LOK |0 003 DE-627 
LOK |0 004 1785622919 
LOK |0 005 20220112043612 
LOK |0 008 220112||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2021-12-30#C59EDF81CD7F06D2B6EEAB9E2D4BD4CE1B5281E8 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/25123392 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw 
STA 0 0 |a AIDS,AIDS,Patents 
STB 0 0 |a Brevets d'invention,Sida,Sida 
STC 0 0 |a Patentes,SIDA,SIDA 
STD 0 0 |a Aids,Aids,Brevetto 
STE 0 0 |a 艾滋病,艾滋病,后天免疫缺乏症后群,艾滋病,后天免疫缺乏症后群,艾滋病 
STF 0 0 |a 专利,愛滋病,愛滋病,後天免疫缺乏症後群,艾滋病,後天免疫缺乏症後群,艾滋病 
STG 0 0 |a AIDS,AIDS,Patente 
STH 0 0 |a Патент,СПИД (мотив),СПИД 
STI 0 0 |a AIDS (μοτίβο),AIDS,Ευρεσιτεχνία 
SYE 0 0 |a Patentwesen,Patente , Acquired immune deficiency syndrome,Erworbenes Immundefektsyndrom